Amnesty International

article

Has the threat of waiving COVID-19 vaccine intellectual property rights had its desired effect?

26 July 2021 | By Hannah Balfour (European Pharmaceutical Review)

In this final article on the TRIPS waiver for COVID-19 vaccines, medicines, diagnostics and technologies, EPR’s Hannah Balfour considers whether it is the correct strategy to overcome COVID-19 treatment inequalities and explores other options.

news

Rich countries buy up majority of COVID-19 vaccine doses, People’s Vaccine Alliance says

10 December 2020 | By Victoria Rees (European Pharmaceutical Review)

According to the alliance, 70 poor countries will only be able to vaccinate one in 10 people against COVID-19 next year after rich countries bought up most prophylactics.